neoantigen-based adoptive cell transfer therapy"> ALFA -Web Direx

About ALFA

Adoptive Cell Transfer Therapy (ACT) refers to the isolation of immunocompetent cells from tumor patients, expansion and functional identification in vitro, and then reinfusion to patients, so as to directly kill tumors or stimulate the body's immune response The purpose of killing tumor cells. Adoptive immune cell therapy mainly includes several categories such as TIL, LAK, CIK, DC, NK, TCR-T, and CAR-T. Neoantigens that are highly immunogenic provide excellent targets for ACT, which uses the patient's own naturally occurring or genetically engineered tumor-fighting lymphocytes. Neoantigen-based adoptive cell therapy, including TILs and genetically engineered immune cells with novel TCRs or CARs, has been successfully used to treat a variety of malignancies. Learn more:neoantigen-based adoptive cell transfer therapy

Business Category

  • Health

Photo Gallery

No Data Found...

Services Offered

No Data Found...

Write Your Reviews

Writing great reviews may help others discover the places that are just apt for them. Here are a few tips to write a good review:

User Reviews

Below Average
Overall Ratings


Business Tag

  • biology

Get Quote

Social profile Business


Address: NEW YORK

Our Location

Company Info

  • Contact name ALFA
  • Contact number 1
  • Email id

Related listings

  • Dentique-The Dental Studio
  • Speech & Language Therapy - Jewel Autism Centre
  • Fitelo

WebDirex new way to Present Your Business

Webdirex business listing directory allows all companies to present themselves online for FREE.

Copyright © 2023 Web Direx